|
|
| March 31, 2008: Dr. Marco Valgimigli Presents the Multistrategy Study |
Dr. Marco Valgimigli presents the MULTIcentre evaluation of Single high-dose bolus
TiRofiban versus Abciximab with sirolimus eluting sTEnt or bare metal stent in acute
myocardial infarction studY (Multistrategy) at the SCAI-ACC i2.08 in Chicago.
Speaker’s bureau: Merck, Medicure
Research grant: Merck,
Sponsorship for interviews at SCAI-ACC 2008 was provided by the Center for Health
Education (CHE) through unrestricted joint educational grants from Scios, Astellas and
Daiichi/Lilly.
[ Download video ] |
|
No comments have been submitted
|